Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02602561 · ClinicalTrials.gov registry record · NA

Effects of HMB Supplementation on Recovery Following ACL Surgery

A NA study, sponsored by Metabolic Technologies.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT02602561: Completed NA study, sponsored by Metabolic Technologies.

NCT02602561 is a NA study that has completed, run by Metabolic Technologies. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02602561, a NA study, has completed, sponsored by Metabolic Technologies.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The anterior cruciate ligament (ACL) is a primary stabilizer of the knee, and thus when ACL injury occurs participation in physical activity is compromised. Reconstructive surgery is often necessary to repair the damage which is then followed by a regimen of physical therapy in order to regain full activity. Nutritional intervention after the surgery could help the patient maintain muscle mass during recovery, thus allowing for a quicker return to normal activity.

Primary Outcome

Measurement of muscle mass will indicate if the active comparator has preserved or increased muscle mass during the post-surgical recovery period.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT HMB

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2015-11
Est. Completion 2017-08
Phase NA
Metabolic Technologies

16 total trials

What the finished NCT02602561 record still lists

NCT02602561 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02602561 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02602561 about?

NCT02602561 is a clinical study titled "Effects of HMB Supplementation on Recovery Following ACL Surgery". The anterior cruciate ligament (ACL) is a primary stabilizer of the knee, and thus when ACL injury occurs participation in physical activity is compromised. Reconstructive surgery is often necessary to repair the damage which is then followed by a regimen of physical therapy in order to regain full ...

What is the current status of trial NCT02602561?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2015-11. Estimated completion is 2017-08.

What interventions are being tested in trial NCT02602561?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), HMB (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02602561?

This trial is sponsored by Metabolic Technologies, which has 16 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02602561's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02602561, the US trial registry maintained by the National Library of Medicine. NCT02602561 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.